Low-dose Ara-C in the treatment of myelodysplastic syndromes
Bone Marrow Transplant
.
1989 Dec:4 Suppl 3:26-7.
Authors
V Bogdanić
1
,
B Labar
,
M Mrsić
,
D Nemet
,
R Serventi-Seiwerth
Affiliation
1
Department of Medicine, Clinical Hospital Center-Rebro, Zagreb, Yugoslavia.
PMID:
2697395
No abstract available
Publication types
Clinical Trial
Randomized Controlled Trial
MeSH terms
Cytarabine / administration & dosage*
Humans
Myelodysplastic Syndromes / drug therapy*
Randomized Controlled Trials as Topic
Substances
Cytarabine